Mesoblast (MESO) had the highest return in Q1 2010 by a US stock with a market cap of $100M+, returning 16,999,900%.
| ASSET | QUARTER | % RETURN |
|---|---|---|
Mesoblast (MESO) | Q1 2010 | 16,999,900% |
Electrovaya (ELVA) | Q1 2010 | 2,033.56% |
Wabash National (WNC) | Q1 2010 | 274.85% |
Coda Octopus (CODA) | Q1 2010 | 246.15% |
Paysign (PAYS) | Q1 2010 | 200% |
Opus Genetics (IRD) | Q1 2010 | 145.45% |
BV Financial, Inc Common Stock (BVFL) | Q1 2010 | 134.33% |
Empire Petroleum (EP) | Q1 2010 | 134.26% |
Novanta (NOVT) | Q1 2010 | 132.94% |
Aurinia Pharmaceuticals (AUPH) | Q1 2010 | 120.86% |
Arrowhead Pharmaceuticals (ARWR) | Q1 2010 | 115.09% |
Radian (RDN) | Q1 2010 | 107.49% |
Red Cat (RCAT) | Q1 2010 | 100% |
Mesabi Trust (MSB) | Q1 2010 | 98.71% |
Hanmi Financial (HAFC) | Q1 2010 | 98.35% |
Aehr Test Systems (AEHR) | Q1 2010 | 92.81% |
MiMedx (MDXG) | Q1 2010 | 91.78% |
Kolibri Global Energy Inc Common stock (KGEI) | Q1 2010 | 91.41% |
TSS, Inc Common Stock (TSSI) | Q1 2010 | 88.71% |
MGIC Investment (MTG) | Q1 2010 | 86.57% |
Radcom (RDCM) | Q1 2010 | 86.45% |
Consumer Portfolio Services (CPSS) | Q1 2010 | 84.43% |
Hudson Technologies (HDSN) | Q1 2010 | 80.56% |
Vera Therapeutics (VERA) | Q1 2010 | 80% |
BioLife Solutions (BLFS) | Q1 2010 | 77.5% |